Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

IL-13 mRNA tissue content identifies two subsets of adult ulcerative colitis patients with different clinical and mucosa-associated microbiota profiles.

Butera A, Di Paola M, Vitali F, De Nitto D, Covotta F, Borrini F, Pica R, De Filippo C, Cavalieri D, Giuliani A, Pronio A, Boirivant M.

J Crohns Colitis. 2019 Sep 10. pii: jjz154. doi: 10.1093/ecco-jcc/jjz154. [Epub ahead of print]

PMID:
31501882
2.

CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative Colitis.

Butera A, Sanchez M, Pronio A, Amendola A, De Nitto D, Di Carlo N, Lande R, Frasca L, Borrini F, Pica R, Boirivant M.

Front Immunol. 2018 Oct 30;9:2511. doi: 10.3389/fimmu.2018.02511. eCollection 2018.

3.

Prevalence of Colonic Diverticulosis in Patients Affected by Ulcerative Colitis: A Prospective Study.

Cassieri C, Pica R, Avallone EV, Zippi M, Crispino P, De Nitto D, Paoluzi P, Brandimarte G, Lecca PG, Elisei W, Picchio M, Tursi A.

J Clin Gastroenterol. 2016 Oct;50 Suppl 1:S33-5. doi: 10.1097/MCG.0000000000000631.

PMID:
27622358
4.

A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitis.

Pica R, Cassieri C, Cocco A, Zippi M, Marcheggiano A, De Nitto D, Avallone EV, Crispino P, Occhigrossi G, Paoluzi P.

Dig Liver Dis. 2015 Nov;47(11):933-7. doi: 10.1016/j.dld.2015.07.011. Epub 2015 Jul 28.

PMID:
26391602
5.

Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.

Zippi M, Corrado C, Pica R, Avallone EV, Cassieri C, De Nitto D, Paoluzi P, Vernia P.

World J Gastroenterol. 2014 Dec 14;20(46):17463-7. doi: 10.3748/wjg.v20.i46.17463.

6.

Defective expression of scavenger receptors in celiac disease mucosa.

Cupi ML, Sarra M, De Nitto D, Franzè E, Marafini I, Monteleone I, Del Vecchio Blanco G, Paoluzi OA, Di Fusco D, Gentileschi P, Ortenzi A, Colantoni A, Pallone F, Monteleone G.

PLoS One. 2014 Jun 27;9(6):e100980. doi: 10.1371/journal.pone.0100980. eCollection 2014.

7.

Biological therapy for dermatological manifestations of inflammatory bowel disease.

Zippi M, Pica R, De Nitto D, Paoluzi P.

World J Clin Cases. 2013 May 16;1(2):74-8. doi: 10.12998/wjcc.v1.i2.74. Review.

8.

Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.

Franzè E, Caruso R, Stolfi C, Sarra M, Cupi ML, Caprioli F, Monteleone I, Zorzi F, De Nitto D, Colantoni A, Biancone L, Pallone F, Monteleone G.

PLoS One. 2013 Jul 26;8(7):e69839. doi: 10.1371/journal.pone.0069839. Print 2013.

9.

The dual role of interleukin-25 in the control of immune-mediated pathologies.

Caruso R, Stolfi C, De Nitto D, Pallone F, Monteleone G.

Curr Mol Med. 2011 Feb;11(1):26-30. Review.

PMID:
21189120
10.

Targeting IL-23 and Th17-cytokines in inflammatory bowel diseases.

De Nitto D, Sarra M, Cupi ML, Pallone F, Monteleone G.

Curr Pharm Des. 2010;16(33):3656-60. Review.

PMID:
21128900
11.

Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages.

Stolfi C, Caruso R, Franzè E, Sarra M, De Nitto D, Rizzo A, Pallone F, Monteleone G.

Immunology. 2011 Jan;132(1):66-77. doi: 10.1111/j.1365-2567.2010.03340.x. Epub 2010 Sep 14.

12.

Interleukin-21 triggers effector cell responses in the gut.

De Nitto D, Sarra M, Pallone F, Monteleone G.

World J Gastroenterol. 2010 Aug 7;16(29):3638-41. Review.

13.

Organ culture system as a means to detect celiac disease.

Picarelli A, Libanori V, De Nitto D, Saponara A, Di Tola M, Donato G.

Ann Clin Lab Sci. 2010 Winter;40(1):85-7.

PMID:
20124336
14.

Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease.

De Nitto D, Monteleone I, Franzè E, Pallone F, Monteleone G.

World J Gastroenterol. 2009 Oct 7;15(37):4609-14. Review.

15.

High incidence of celiac disease in patients with systemic sclerosis.

Rosato E, De Nitto D, Rossi C, Libanori V, Donato G, Di Tola M, Pisarri S, Salsano F, Picarelli A.

J Rheumatol. 2009 May;36(5):965-9. doi: 10.3899/jrheum.081000. Epub 2009 Mar 30.

PMID:
19332639

Supplemental Content

Loading ...
Support Center